Skip to main content
Caplight Logo









mo:re

mo:re

Private
HamburgHealthcare & Life Scienceshttps://more.science/

Last Round

Seed

Mar 26, 2025

Total Funding Raised

$2.48M

Company Overview

mo:re is a biotechnology company that has developed a lab platform, the MO:BOT, which automates 3D cell culture and downstream assays to standardize drug discovery and reduce reliance on animal testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Workflow Automation

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

lab automation3D cell cultureorganoid researchdrug discoverybiotech equipmentpreclinical researchworkflow automationlab-on-a-chiphigh-throughput screeningautomated cell cultureorgan-on-a-chipquality controltoxicology testingbiotech lab techautomated liquid handling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

mo:re Comparables

Compare mo:re with similar companies based on industry and business-model similarity.

mo:re comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Open Culture Science
88%
Celloid
84%
Cellaven
84%

mo:re Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 26, 2025
GrantJul 1, 2022

Key People

Founding team and executive leadership

Lukas Gaats

CEO

Executive Team

mo:re Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2025

    $2.48M round led by High-Tech Gründerfonds.

mo:re Filings

Explore SEC and related filing metadata, where available.

mo:re filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about mo:re's valuation, stock price, and market status.

Is mo:re a public or private company?

mo:re is a private company.

What is the current stock price of mo:re?

mo:re is a private company with no public stock price. No recent secondary market data is available.

How much is mo:re worth (valuation)?

Valuation information for mo:re is not publicly available.

Can I buy mo:re stock?

mo:re shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was mo:re's last funding round?

mo:re's most recent funding round was Seed on March 26, 2025.

Who are the main investors in mo:re?

Key investors in mo:re include InnoVentureFonds, NEDGEX.

Will mo:re IPO soon?

No public IPO plans have been announced for mo:re.

How can I track mo:re secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor mo:re's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHamburg
Employee Range12
Year Founded2023
Last FundingMar 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?